The Role of IL33/ST2 Axis in ARDS Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02492204

Enrollment

200

Registered

2015-07-08

Start date

2015-07-31

Completion date

2019-12-31

Last updated

2019-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Brief summary

The main objective is the study of the role of IL33/ST2 axis in the pathogenesis of ARDS, it´s value as prognosis marker and as therapeutic target.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* ARDS * Risk pathologies to develop ARDS (sepsis, pancreatitis, pneumonia, massive transfussion, politraumatics)

Exclusion criteria

* Age under 18 * Pregnancy * Undergoing a clinical trial

Design outcomes

Primary

Measure	Time frame
Prognostic value of the IL-33/ST2 axis in patients with ARDS.	60 days

Secondary

Measure	Time frame
Value of IL33/ST2 axis to predict development of ARDS in risk patients	60 days

Countries

Spain

Outcome results